Switchable hydrogenation with a betaine-derived bifunctional Ir-NHC catalyst.
A bifunctional iridium catalyst based on the 'uracil-abnormal NHC' hybrid ligand platform was developed for switchable hydrogenation of quinoxalines. Control studies suggested heterolytic H2 activation via a metal-ligand bifunctional operation to generate Ir-H and an adjacent protic O-H group for facile H+/H- transfer to quinoxaline. The presence of a base blocked the most essential H+-transfer step thus switching off the catalysis, while an acid stimulus reversed the action to switch on the reaction again.